首页> 外文期刊>Virchows Archiv: an international journal of pathology >The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
【24h】

The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.

机译:腹膜后切除切缘和血管受累是决定胰十二指肠切除术后胰头腺导管癌生存率的重要因素。

获取原文
获取原文并翻译 | 示例
           

摘要

The prognosis of ductal adenocarcinoma of the pancreas is still poor. We analysed the factors that have a major influence on the survival of patients. Surgical specimens from 51 patients with ductal adenocarcinoma of the head of the pancreas were examined for tumour size, histological type, grade and local extension. In 7 patients the retroperitoneal resection margin was involved either macroscopically or histologically. Their mean survival was 10.6 months (1-17 months), compared with 22.7 months for the 44 patients with curative R0 resection. In 10 patients large vessels (portal and/or mesenteric vein) had to be resected; they survived for only 2-11 months, with a mean of 5 months (P<0.05). Non-R0-resected patients and patients in whom tumour-invaded vessels had to be resected constitute a high-risk group with a significantly shorter mean survival of 8.8 months, compared with 24.3 months for R0 resected patients without vessel invasion (P<0.05). Lymph node metastases were seen in 35 of 51 patients. Survival analysis based on nodal status revealed a mean survival of 33 months for patients staged as N0, 21.4 for N1a patients and 14 month for N1b patients. The differences were not statistically significant, however. Our data suggest that tumour invasion of the retroperitoneal resection margin and large vessel involvement are the major factors determining survival in patients with pancreatic cancer.
机译:胰腺导管腺癌的预后仍然很差。我们分析了对患者生存有重大影响的因素。检查了51例胰头导管腺癌患者的手术标本的肿瘤大小,组织学类型,分级和局部扩展。在7例患者中,宏观或组织学上都涉及腹膜后切除边缘。他们的平均生存期为10.6个月(1-17个月),而44例行R0切除的患者为22.7个月。在10例患者中,必须切除大血管(门静脉和/或肠系膜静脉)。他们仅存活2-11个月,平均5个月(P <0.05)。非R0切除的患者和必须切除肿瘤侵袭性血管的患者构成高危组,平均生存期显着缩短,为8.8个月,而R0切除的无血管侵犯患者的平均生存期则为24.3个月(P <0.05) 。 51例患者中有35例淋巴结转移。根据淋巴结状态进行的生存分析显示,分期为N0的患者的平均生存期为33个月,N1a患者为21.4,N1b患者为14个月。但是,差异在统计上并不显着。我们的数据表明,腹膜后切除边缘的肿瘤浸润和大血管受累是决定胰腺癌患者生存的主要因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号